The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug – Science   Commentaries on Twitter Remdesivir, despite failing in Solidarity trial, received FDA approval without input from outside advisory group. EU cut pricing deal with Gilead without knowing Solidarity data. @kakape and I explain in "The ‘very, very bad look’ of remdesivir" […]

The post The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug appeared first on Links Medicus.